MENU
+Compare
ANEB
Stock ticker: NASDAQ
AS OF
Aug 11, 04:58 PM (EDT)
Price
$2.32
Change
-$0.09 (-3.73%)
Capitalization
98.9M

ANEB Anebulo Pharmaceuticals Forecast, Technical & Fundamental Analysis

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction... Show more

ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ANEB with price predictions
Aug 08, 2025

ANEB sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for ANEB moved above the 200-day moving average on July 25, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +8 3-day Advance, the price is estimated to grow further. Considering data from situations where ANEB advanced for three days, in of 157 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 58 cases where ANEB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ANEB moved out of overbought territory on July 30, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator moved out of overbought territory. In of the 14 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ANEB as a result. In of 104 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ANEB turned negative on August 05, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANEB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ANEB broke above its upper Bollinger Band on July 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANEB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.348) is normal, around the industry mean (18.662). P/E Ratio (0.000) is within average values for comparable stocks, (54.033). ANEB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (286.048).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANEB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ANEB is expected to report earnings to rise 25.00% to -5 cents per share on September 17

Anebulo Pharmaceuticals ANEB Stock Earnings Reports
Q2'25
Est.
$-0.05
Q1'25
Beat
by $0.04
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.06
The last earnings report on May 13 showed earnings per share of -3 cents, beating the estimate of -7 cents. With 101.31K shares outstanding, the current market capitalization sits at 98.90M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1017 Ranch Road 620 South
Phone
+1 512 598-0931
Employees
2
Web
https://www.anebulo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DCTIF0.040.01
+50.09%
REGENERA INSIGHTS INC.
JXHGF5.27N/A
N/A
Eneos Holdings Inc.
CNDCF9.11N/A
N/A
Canadian Banc Corp
NNOCF0.19N/A
N/A
Nanoco Group Plc
SDCVF63.03N/A
N/A
Sa des Ciments Vicat

ANEB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANEB has been loosely correlated with ABVX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ANEB jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
+0.30%
ABVX - ANEB
46%
Loosely correlated
+0.16%
ABCZF - ANEB
31%
Poorly correlated
N/A
CLSD - ANEB
30%
Poorly correlated
+6.40%
AVXL - ANEB
28%
Poorly correlated
-1.20%
ALDX - ANEB
28%
Poorly correlated
+1.64%
More